Regulation of Tyrosinase mRNA in Mouse Melanoma Cells by α-Melanocyte–Stimulating Hormone  by Rungta, Deepa et al.
Regulation of Tyrosinase mRNA in Mouse Melanoma 
Cells by a-Melanocyte-Stimulating Hormone 
Deepa Rungta, Todd D . Corn, and Bryan B. Fuller 
Deparonenc of Biochclll istry and Molccular Biology, University of Oklahoma. Health Science Ccntcr. Oklahoma City. Okbhoma. 
U.S.A . 
Cloudman S-91 ll"lOUSe melanoma cells respond to 
a-ntelanocyte-stitnulating hormone) by demonstrat-
ing a marked increase in tyrosinase activity (O-diphe-
nol-02 oxidoreductase, EC 1.14.18.1). This increase is 
the result of increased levels of tyrosinase mRNA 
with a subsequent increase in tyrosinase abundance. 
Our studies were carried out to determine the effect 
of ntelanocyte-stimulating horn"lone on tyrosinase 
gene transcription and to measure the kinetics of the 
horntone- induced increase in tyrosinase D"lRNA. 
When melanoma cells were exposed continuously to 
melanocyte-stimulating hormone for 6 d. a large but 
transient increase in both tyrosinase mRNA abun-
dance and enzyme activity were observed. The max-
imUnt increase in tyrosinase mRNA occurred 60 h 
after melanocyte-stimulating horll"lone stiulUlation 
and was followed by a decline in ll"lessage levels even 
though cells were continuously exposed to horll"lone. 
Results of nuclear run-off transcription assays showed 
C loudman S-91 mouse mC.lanom3 CCII.S demonstratc a m arkcd incrcase in tyrosinase activity, the rate-Ijnuting enzyme for melanin synthesis, in responsc to trcatmcnt with the peptide hormone, melano-cyte-stimu lating hormon e (a-MSH) (Wong and 
Pawelek, 1973; Fuller and Viskochil, 1979). The hormone-medi-
ated increase in enzyme activity is m edi atcd through the second 
messengcr, cAMP, beca use treatment of cells with either analogs of 
cAMP, such as dibutyrl cAMl), or with inhibitors of cAMP 
phosphodiesterase, such as theophylline or isobutyl methylxan-
chine, will also promote an increase in tyrosinase activity (Pawelek 
ef (/1, 1973; Fuller el ai, 1987). Recent studies have shown that 
traosfection of melanoma cells with constructs expressing the 
catalytic subunit of cAMP-dependent protein kinase will cause an 
increase in tyrosinase activity, and this fmding provides additional 
support for the role of cA MP in tyrosinase induction (Fuller et ai, 
1993). The MSH-mediated increase in ty rosinase activity is strictly 
dependent upon continued cellular RNA and protein synthesis. 
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that melanocyte-stin"lulating honnoue caused a slow 
increase in the rate of transcription of the tyrosinase 
gene with a maxin"lal 6-fold stimulation occurring at 
48 h . In cells treated with the ribonucleic acid syn-
thesis inhibi tor, 5, 6-dichloro-1-/3-D-ribofurauosyl-
benzimidazole, tyrosinase mRNA levels decayed with 
a half-life of 4-5 h. This decay rate was unaffected by 
treatment of cells with melanocyte-stimulating hor-
mone, indicating that the hormone does not act to 
stabilize tyrosinase ribonucleic acid. Inhibition of 
protein synthesis by treatment with cyclohexiullde 
had no effect on the melanocyte-stimulating hor-
mone-induced increase in tyrosinase messenger ribo-
nucleic acid levels suggesting that ongoing protein 
synthesis is not required for, at least, the initial 
stin"lulatiou of tyrosinase gene transcription by mela-
nocyte-stimulating horll"lone. Key 1V000ds: tmJlscriptioll/ 
cAMP/cycfohe.vimide.j II/vest Del'llratoI107:689-693, 1996 
because exposure of cells to either the transcriptional inhibitor. 
a -amanitin, or the translational inlubitor, cycloheximjde, will 
completely block MSH action (Fuller and Hadley, 1979; Fuller and 
Viskochil , 1979; Fuller el (/1, 1987). Recent studies have shown that 
either MSH, dibutyryl cAMP, or isobutylme tllyb:anthin e will in-
duce an increase in tyrosinase mRNA in m e lanoma cells with a 
subsequent increasc in enzyme abundance (Hoganson el ai, 1989). 
Thjs hormone-mediated increase in tyrosinase mRNA level s could 
e ith e r be the result of an in crease in tyrosinase gene transcription. 
o r the result of tyrosinase mRNA sta bilization , or both. H ormon es 
that act through cAMP havc been shown to act through e ith er 
m echanism (Montmini el ai, 1986; Hod and Hanson. 1988; Roesler 
cl ai, 1988). In regard to an MSH stimulation of tyrosinase gen e 
transct"iption by cAMP, no consensus cAMP-regu latory clement 
(CRE) sequence is present in the promotor reg ion of the tyrosinase 
gene. and furth er, chorampheni col acetyl tnlllsferase (CAT) re-
porter expression studies have f.,iled to identify a cAMP-responsive 
c lement within the promote r region of the tyl"Osinasc gene (Kluppel 
cl ai, 1991; Ganss el ai, 1994). Our studies were ca rried o m to 
determine whether MSH stimulates tyrosinase gene transcription 
or, alternatively acts to stabilize tyrosinase mRNA. The results 
reportcd he re show that the primary efFect of the hormon c is at the 
level of tyrosinase gene transcription . 
MATER.IAlS AND METHODS 
Thc Cloudl11an S-91 l11 elanol11a cell s used ill this snldy werc originall y 
obta illcd frol11 the AlI1cricall Type Culture Collection ccll repository (CCl 
0022-202X/96/S10 .50 • Copyright © 1996 by The Society for IlIvcstigativc Dermatology, Inc. 
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53.1) (Rockvil le, MD). T he radioisotopes, [a_32P]dATP and [' H]tyrosine 
(L-ring-3 ,5-J H), were purchased from Dupont-New England Nuclear 
(Boston, MA). Horse serum was purchased from H yClone (Logan, UT), 
and Ham 's F- I O lJu trient med ium was obtained fro m Mediatech (W"shi ng-
ton , DC). P. .... Nas in, -DNase I, lGcl1ow, and all other restr iction cnzynlcs were 
purchased from Promega (M adison , W I) . a-MSH , cycloheximide, 5,6-
dichloro-l-/3-D-ribofuranosylbenzimidazole (DRll), and a\l other chemi-
ca ls were purchased fi'om Sigma (St. Louis, MO). 
Cell Cultures Melanoma cells were grown in \-lam's F-10 nu tri ent 
medium fortified with 10% ho.rsc serum, penicillin (100 U per ml) , and 
streptomycin (100 ILg per ml) (Fu ller cl ai, 1987). Stock cul tu res were 
maintained in 175-cm2 1- li ter Falcon flasks (Becton D ickinson, Lincoln 
Park, NJ) and subcultured weekly. Cell s wcrc removed frol11 flasks with 
Hank's Balanced Salt Solu tion conta ining 5 mM ethylenediamine tetraacetic 
acid (EDTA). Cell counts were made with " Coulter Counter. 
Tyrosinase Assays To determine tyrosinase activity in cell homogenates , 
the tyrosine hydrox ylase activity of the enzyme (Pomerantz, 1964) was 
determined as previo usly described (Fuller cl ai, 1987). B6efly, cell pellets 
were sonicated in 0. 1 M sodium phosph"te butte r (PH 6.S) and 50- ILl 
aliquots were added to 0.5 ml of a rcaction mixture conta ining 0.1 mM 
tyrosine, 2 ILC i of [' H]tyrosine per ml , 0 .1 mM L-dihydroxyphenylalan ine, 
and 0. 1 mM phenylmethylsul fony l fluoride. Following incubation at 37°C 
for 2 h, reactions were terminated by the addition of 1 ml of charcoal (10'Y., 
wt/vol in 0.1 N H C I). Samples wcre centrifuged, and the supernatant was 
removed for determination of the amoun t of ' H 20 produced. 
RNA Analysis Tyrosinase mRNA levels were determined as described 
elsewhere (Hoganson c/ ai, 1989; Fuller cf ai, 1990). Total RNA was 
prepared from melanoma cells by the method of C homczynski (Chom-
czynsky and Sacchi , 1987). For northern blot anal ysis, 20 ILg of tota l I~A 
were electro pho resed on 1.2% formaldehyde agarose gels , transferred to 
nylon membranes, and probed with a [3 2PJdATP-labeled tyrosinase DNA 
probe (Fu ller el ai, 1990) . Fo r slot blot no rthern analysis, 10 ILg of tota l 
l~A were denatured in 10 mM NaOH and app lied to a nylon membrane 
assembled into a Bio-Rad (Richmond, CAl slot blot apparatus. Following 
transfer of RNA, fi lters were hybridized to either a tyros inase or actin 
cDNA probe as described above. 
After auto radiography, RNA levels were quantitated on a Molecu lar 
Dynamics (Sunnyva lc, C Al model 300A computing densitometer. To 
control fo r variability in loading or I~A integrity, blots wcre repro bed with 
an actin DNA probe. AIl tyrosin ase mJ~A levels were normalized to the 
anlo nn t of ac tin ll1cssagc in th e Sa l11C salnpl c o r to the density of ribosOina l 
bands on the blot. 
Nuclear "Run Off" Transcription Assays Nuclei from MSl-I-treated 
o r un treated mouse melanoma ce lls were ha rvested by a modification of the 
procedure described by O'Conner and Wade (1992). Briefly, ceUs fro m 
175-cm 2 flasks were scraped off with a rubber policeman into 5 1111 of cold 
phosphate-bufie red sa li ne, and pell eted at 500 X g for 5 min . Cells were 
then resuspeuded in co ld cel l lysis buffer [0.25 M sucrose, 50 111M HEPES 
(pH 7.4), 5 mM MgC I2 , 0. ·1% T riton XIOO] and homogenized with 20 
strokes in a Dounce homogenizer (B pestle) . The homogenate was then 
layered on a co ld sucrose cushion [0.5 M sucrose, 50 111M HEPES (pH 7.4), 
5 mM MgCl, ] and cen trifuged at 1 000 X g for 10 min at 4°C. I'ell eted nuclei 
were resuspended in 200 ILl of nuclei storage bu ffc r containing 40% 
glycerol, 50 mM Tris(hydroxymethyl) -aminomethane (Tris)-HC I (1'1-/ 8.3), 
5 mM MgCI2 , and 0.1 mM EDTA, immedia tely frozen in a dry ice/acetone 
bath , and stored at -SO°C until used for assay. A L- ILI aliquot of the 
resuspended nuclei was lysed in 0.1 % sod ium dodecyl su lf.,tc (SDS) and 
used to determinc the concentration of the nuclei by measuring the 
absorbance at 260 and 230 lID' (Ka lb and Bernlolu:, 1977). 
I~A labeling in nuclei was carried o ut by a slight modification of the 
method described by O'Conner and Wade (1992). T hawed nuclei (200 ILl) 
were placed in 200 ILl of tra nscriptio n bufl"er (35% glycerol, ·10 mM 
T6s-HCI, pH 7.5 , 5 mM MgCI2, 300 mM KCI), 0.5 mM each ofguanosiue 
triphosphate, cytid ine triphosphate, adenos ine triphosphate, 125 ILCi 
[J2 P] uridine trip hosphate (3000 C i/ mmol), and 0.5 mM dithiothreitol) 
along w ith 40 U of RNasin (a RNase inhibi tor), and reactions were 
incubated at 30°C for 40 min. After incubation nuclei were digested with 50 
U RNase free DNase / and 10% (vo l/vol) 10 mM CaCI2 at 37°C fo r 15 min. 
Samples werc furth er treated for 30 min at 37°C with 10% (vol/vol) lO X 
SET buffer (5% SDS , 50 111M EDTA, 100 111M T ri s-H C I, 1'1-1 7.4) , 10% 
(vol/vol) 0.4 mg proteinase K per ml, and 10 ILll 0 mg yeast per ml. N uclear 
RNA was then iso lated by the method ofChomczYllski (Chomczynsky and 
Sacchi , 1987). Unincorpora ted [32p]UTP was removed fro m the labeled 
transc6pts by precipi t"ting the RNA twice in 1 M NH"OAc and abso lu te 
ethano l. Nuclear l~A was di ssolved in 100 ILl of 0.5°;', SDS, and total 
TH E JOURNAL O F INVESTIGATI VE DEI~MATOLOGY 
radioactivity was determined by scinti ll ation coun ting of a l-ILI aliquot oC 
labeled nuclea r RNA . 
For RNA hybridization, nylon membranes containing 5 ILg each o f 
Jine"rized pllR3 22 plasmid DNA, pBR322 with actin cDNA insert, and 
pBR322 with mouse tyrosin ase eDNA insert were prepared using a slot blot 
appara tus (Bio-Rad, I-Iereules, CAl . Each plasmid DNA was lineari zed with 
the appropriate restriction enzyme and denatured in 0.4 N NaOH, 10 111M 
EDTA at 100°C fo r 10 min. After binding of the DNAs, membranes were 
then hybridized in 2 ml of butte r containing 50% formamide, J .5 X 0.2 M 
sodium chloride, 0.01 M sodium phosphate, 0.00 ·1 M EDTA, 1% SDS, 0.5% 
Blotto (Bio-Rad), 200 ILg carrier I~A per ml, 500 ILg denatured salmon 
sperm DNA per ml, and :l 2 P_ labcled sample l~A at 72°C for 2- 3 d. After 
h ybl·idization the 1l1crnbrancs were washed at r 00l11 tClllj)craturc for 15 nUll 
in each of the fo ll owing: 2 X sod ium citrate/sodium chloride buKer 
(SSC) /0. 1 % SDS, 0.5 X SSC/O. l 'y.. SDS, and 0.1 X SSC/O .l % SDS. 
Membranes we re then exposed to autorad iographic fi lm for 3- 5 d_ Amo -
r<ldiograms were quantitated on a Molecular Dynamics model 300A com-
puting densitometer, and tyrosinase mRN A values were normalized to the 
amount of labcled actin mRNA hybrid ized to the actin DNA pn:sent on tile 
same blot. 
RES ULTS 
Continuous Exposure of Melanoma Cells to MSH Causes a 
Transient Increase in Tyrosinase mRNA We first examined 
the effect of MSH o n tyrosinase mRNA expressio n in m elanoma 
cells. As sh own in F ig 1, a marked inc rease in the level of tyrosinase 
mRNA was observed w h en cell s were tre ated with 2 X 10 - 7 M 
MSH. T he response was detected as ea rl y as 4 h (data not shown) 
and reached a ma»'lmum 8- to 1. O-fold increase over con tro l levels 
60 h after h orm o n e addition. Message levels th en starte d to decline 
even though cells were con tinu o usly ex posed to MSH and b y 72 h 
h ad stabili zed at a level that w as 2- 3 times control va lues. The 
M SH-induced in crease in tyrosinase activity reach ed a ma ximum at 
about 72 h (16- to 20-fo ld increase ) , and then also de clined . 
Tyrosinase mRNA Decays Rapidly After Removal of MSH 
T h e e ffec t of th e removal of MSH o n th e decay of tyrosinase 
mRNA and ac tivity was examined n ext. Cell s were exposed to 
MSH for 24 h, washed extensively, and then inc ubated in the 
ab sen ce of MSH for various len gths of time before isolation of 
RNA fo r northe rn blot analysis. As sh own in F ig 2 , tyrosinase 
mRN A leve ls con tinu ed to increase slightly for 4 h fo llowing the 
rem oval of ho rmone, after which tim e the message levels began to 
dro p , reachillg b asal levels by 20 h. Sim ila rl y, tyros inase activi ty 
incre ased for about 6 h after th e horm o n e was re moved and th en 
a lso dropped to basa l levels. 
MSH Stimulates Tyrosinase Gene Transcription Increased 
abundan ce of tyros inase mRNA by MSH co uld e ithe r be due to 
increased transcription of the tyrosin ase gen e, o r to increased 
sta bil iza ti on of the IllI~A, 01' to both. In o rder to d etermine how 
MSH increases tyrosinase mRNA levels, th e effect of MSH on the 
transcL; ption rate of th e tyrosinase gen e was measured by "nu clear 
run oW' experime nts. Nuclei w ere isolated at diR-erent times afte r 
MSH treatm en t, and th e nascent t ranscripts w e re labe led with 
C2 P]UTP. T h e labe led transcripts w e re then h ybridized to nylon 
m e mbranes con ta ining pBR322 DNA (as n e gative control) , 
pBR3 22 con ta ining actin cD NA insert (as pos.itive con tro l) , and 
pBR322 containing a tyrosin ase cDNA inser t. As shown in Fig 3 , 
MSH cau sed a marke d increase in the rate of tyros inase gene 
tran scrip t io n . T he increase was evident within 3 h after MSH 
treatm ent and reached a m aximuIll level 48 h after h ormone 
treatment. T h e 6- fold increase in tyrosin ase gen e transcription 
o b served at 48 h correlated close ly with th e 6- to 8-fold in crease in 
tyrosin ase mRNA abundance measured in cell s treated with MSH 
for 60 h . T h ese results indicate that th e MSH-mediated increase in 
tyrosinase mRNA resul ts primarily from increased tyrosinase gene 
transcrip tion , and that the maximum induc tion of the gene by MSH 
is a re lative ly slow response. 
MSH Does Not Alter the Decay Rate of Tyrosinase mRNA 
T h e effect of MSH 011 th e stabiJi ty of tyrosinase mRNA w as 
determine d ne xt by u sin g ORB as all inhibi tor ofl~A polymerase 
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Figure 1. MSH causes a trans ient increase in tyrosinase mRNA and 
activit:y. Mouse melanoma cells were seeded into 75-cm2 flasks and either 
left untreated or treated with MSH (2 X 10- 7 M) for various times . Every 
24 h, medium was rep laced with fi'esh medium and for MSI-l-treated 
cultures, fresh hormone was added. At the times indicated, cell s were 
removed, tyrosinase activity was determined from one fifth of the cells. and 
the remainder of the cells were processed for RNA. Tyrosinase mRNA 
le';els were determined by northern blot analysis as described in Maleri"ls 
Qlld Methods . Tyrosinase mRNA (_); tyrosinase activity (~). Tyrosinase 
activity for un treated (control) cu ltures was 0.31 nmol of ' H 20/1 0" cells' 
hour. T he normalized (to actin) densitometlic value for tyrosinase mRNA 
from wltreated cell cultures as determined with a Molecular D)'11amics 
mode) 300A computing densitometer was GGO volume units. V:dues arc 
averages of triplicate determinations :': SD. T he autoradiogram shown aiJolle 
the graph is of a northem ,malys is of tyrosinase mRN A from cells treilted for 
various times with MSH. C, control tyrosinase mRNA; M. tyrosinase 
mRNA from MSH-treated cell s. Experiments were repeated twice with 
similar results. 
IT transcription . The efl:ectiveness of DRB in suppressing the 
MSH-induce d increase in tyrosinase mRNA was determined by 
treating cell cultures for 30 min with the drug prior to adding MSH. 
Cells -were then exposed to either MSH alone, DRB alone, or to 
MSH plus DRB for 8, 16, and 24 h. At these times, ceLls were 
processed for RNA, and tyrosinase mRNA levels were determined 
by northern blots. Tyrosinase mRNA levels in MSH-treated cells 
were 1.3,2.25, and 3.5 times hig her than control levels at 8,16, and 
24 b, respectively, and tlus induction was completely inhibi ted by 
treatment of ce Lls with DRB, indicating that the drug is an effective 
transcriptional inhibitor in m elanoma ceLls . 
To determine whether MSH acts to increase the stability of 
tyrosinase mRNA, melanoma cells were first treated with MSH for 
24 h to increase tyrosinase mRNA levels, I;nsed to remove 
hormone, and then treated with eithe r addi tional MSH, with DRB 
without MSH, or with DRB and MSH together. If MSH increases 
the stability of tyrosinase mRNA, one would expect the decay of 
tyrosinase mR.NA levels to be slower in cells treated with both 
MSH and DRB, as compared to cells treated with DRB a.lone. As 
shown jn Fig 4, tyrosinase mRNA levels decayed with a half-life of 
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Figure 2. Tyrosinase mRNA and activity decays rapidly after 
removal ofMSH. Mouse melanoma cells were trcated w ith MSH for 24 h, 
after which time the hormone was removed, cells were rinsed, and fresh 
medium was added. Cells were removed at the indicated times and 
tyrosinase activity (~) and tyrosinase mRNA levels (_) were detennined as 
described in IIlfalerials fl/Id NJet/",ds . T he T = 0 time point is the time at which 
the hormone was removed from MSH-treated cells after a 24-h exposure. 
At this time, tyrosinase activity in untreated cultures was 0.15 nmol of 
' H20 / 106 ce lls' hour and in MSI-l-treated cells the va.lue was 0.83 nn101 of 
' H 20/10" cells . hour (550% of untreated cultures) . The normalized 
densitometric valuc for tyrosinase mRNA in untreated cell s was 330 volume 
units , and for MSH-treated cells th.is value was 940 (285% of control). 
Values arc averages of triplica tes :': SD. The iI/SCI shows a slot blot 
autoradiogram of a northern analysis of tyrosinase from untreated and 
MSH-treated cell s. As can be observed, by J 6 h, tyrosinase mRNA levels 
have decayed to almost basal levels. C, Tyrosinase mRNA from control 
cells; M, tyrosinase mRNA £i'om MSI-l-treated ccl.l s. T hese experiments 
were repeated twice with similar results. 
abou t 4 h after treatment with DRl3 w hether or not MSH w as 
present, indicating that MSH does not have a pronounced stabiliz-
ing effect on tyrosinase mRNA. 
MSH Stimulation of Tyrosinase Gene Transcription Does 
Not Require Protein Synthesis To detennine whether the 
MSH induction of tyrosinase gene transcription required de /l 0IJ() 
protein synthesis, cycloheximide was used to inhibit protein syn-
thesis, a.nd the effect of this inhibition on the MSH induction of 
tyrosinase mRNA was measured. Cells were treated with cyclo-
heximide for 30 min and then eithe r MSH or MSH plus cyclohex-
imide was added for various lengtlls of tim e, up to 12 h. As shown 
in Fig 5 , the MSH-induced increase in tyrosinase mRN A was not 
affected by cycloheximide treatment, indicating tbat new protei.n 
synthesis is not required for at least the initial stimul ation of the 
tyrosinase gene by MSH. 
DISCUSSION 
Previous studies from our laboratol'y and 6'om others have shown 
that eithe r MSI-I (Fuller ct aI, 1990, 1993; Awea eT aI, 1993), cAMP 
analogs (Hoganson eT aI, 1989), or phosphodiesterase inhibitors 
such as theophylline or isobutylmethylxa.nthine (Kwon el aI, 1988) 
will cause an increase in tyrosinase mRNA ill mouse melanoma 
cells. The results presented here show that MSH increases tyros i-
nase mRNA levels in melanoma cells primarily by increasing the 
rate of tyrosinase gene tranSc\;ption. The increase in transcription 
corre lates well with the increased abundance of the message 
detected on northern blots. T he m axim um stimulation of transcrip-
tion by MSH occurred at 48 h , and the maximum level of cellul ar 
tyrosinase mRNA was evident 60 h after hOl11lOne treatment. 
A lthoug h the amelanotic C lo udman mouse melanoma cell line use d 
in our studies showed a ma)';ma l increase in tyrosinase mRNA at 
60 h, this may not be typica l for all mouse melanoma cell Jines. 
Recent studies with jB/MS mouse melanom3 cell cul tures (Aroca 
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Figur e 3. MSH stimulates tyrosinase gene transcrip tiou. Cells were 
trea ted with MSH (2 X 10- 7 M) for the indicated ti mes. and nuclei were 
isolated fo r " nuclea r run-o ft" tran scri ption assays as d escribed in N/nf erillis 
al/{I Methods. Values arc the results of densitometri c sc"nn i n~ of autoradio-
g ral11s an d arc exp ressed w ith refe re nce to the sig n al for actin. N o rnla lizcd 
densitometric va lues from contro l ce lls were 73 volumetri c ulli es. Data 
points rep resen t the avera~es of triplj cate determination ± SO. T he illset is 
an autoradiogram of newly fo rmed tyrosinase I11 R NA 'lI1d actin hybridized 
to their respective ONAs on a fi lter (see Malerials alld Methods for deta il s). 
T he no rlll ali zcd tyrosinase Illl'tNA dCJl sito l11Ctric va lue fr0 l11 con tro l nucle i 
was 294, and for MSH-treated nuclei the va lue was 221 1. 
et "I , 1993) and w ith the B-1 6 m o use m e lano m a cell line (G allSs et 
" I, 1994) ha ve sho wn that tyrosinase mRN A le ve ls ill these cells 
continue to increase fo r a t least 4 d after the star t o f h0 l'l110 ne 
treatment. 
Although it is clear th at cAMP is respo nsible fo r the induction of 
the tyrosin ase gene, the m o lecular path way thro ug h w hich cAMP 
~I cts is not kn own . We have shown that tyrosinase activ ity is 
increased in m e lan o m a cel.l s transfected w ith a vector th at ex presses 
th e cata lytic su buni t of cAMP-dependent protein kinase (kinase A) 
(Ful.l el· et ai, 1993) . T his fi nding suggests th at cA MP m ost like ly acts 
th~'ough kinase A to stimulate tyrosinase gene transcriptio ns. A 
recen t re po r t b y Eng laro and co-workers , however, sugges ts th at 
cA MP m ay exert its stimul atory effects o n the tyrosinase gene 
indirectl y. In this m o d e l, the in crease in in tr acellular cAMP caused 
b y trea tment of m e lano m a cells w ith M SH leads to a stimulation of 
mitogen-acti vated protein kinase , which then translocates to th e 
nucleus w here it activates th e transcript io n facto r , A P-1. T he 
fos- related an tigen-2/J unD he tero dimer m ay the n bind to an AP-l 
regulatory e le m e n t o n the tyros inase gene p rom oter , there by 
activating the gene (En glaro et " I, 1995) . Altho ug h there is a 
p u tative AP-1. site in the tyrosinase gene pro m o ter regio n , w o rk 
from o ur labo rato ry and fro m others suggests that this regio n m ay 
actually se rve as an inhibi tory regul atory c le m en t fo r the tyros inase 
gene (FuUer ,-/ " I, 1990) . 
Genes that are t ranscriptio n ally induced b y cAMP have been 
classifi ed into two gene ral categories (Roesle r et ai, 1988) . G ro up I 
genes are induced wi thin minutes of cAMP trea tment and are 
cycl o heximide insensiti ve. Genes in gro up II , o n the o ther hand, are 
induced slow ly and h ave been sh o wn to be sensitive to cyclohex-
im ide t rea tme n t, suggesting that the syn thes is of som e intermediary 
p rote in , m ost likely a transcriptio n f.1ctor, is required fo r the ir 
indu ctio n . It was thus interes ting to find that the M SH indu ctio n of 
the tyros in ase gene did not rea lly fi t w ith e ith e r a group I o r 1I 
response because the inductio n w as slow but was not a ffected b y 
cycloheximide trea tme nt. T his type of respo nse is no t uniqu e to the 
tyrosin ase gene bu t has been demonstrated in other cAMP-respo n-
sive system s. A similar pheno m eno n has been o bserved for the 
human cho rio nic gonado tro pin {3-subull.it gene in which the induc-
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Figure 4. T yrosinase mRNA decays with a half-life of 4 11 aud this 
rate is not affected by MSH . Cell s were seeded into 75-cm2 fl asks and 
induced with MSH (2 X 1. 0- 7 ) fo r 24 h. At this time the normalized 
densitometri c value for tyrosinase m RNA from control ce ll s was 132 
volumetric uni ts, and fro l11 MSH-treatcd cell s till.! va lue was 935 volumeo:ic 
uni ts. Flasks were the n rinsed to relTIOVC h O l"1110 Il C . and cells were incu bated 
in medium with nO additions (6 ) , Or with either MSH (A), ORB (0), Or 
MSH and OR.B (_ ). At the times iJldicated, ce lls were removed and 
tyrosinase I11R.NA levels were determincd by northern blot analysis. Half_ 
life va lues were determined from the slope of the line, which was deri ved 
by linear regress ion analysis. T he values represent the average of triplicate 
dctc n n inatio l1 ± SD. 
t io n o f the gen e by cA MP is quite slo w altho ug h the respo nse is 
inde pende n t o f continue d cellula r t ransla tion (Fuh et ai , 1989). 
With rega rd to th e tyrosinase gene, the d ata suggest tha t w hatever 
f.1c to rs arc need ed fo r the ini tial inductio n of the gene, they arc 
already presen t in th e unstimulated ce ll . G ive n the slow induction 
response, however, it is possibl e that, unde r the influence of MSH 
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Figure 5. MSH stil11ulates tyrosinase l11RNA levels in cyclobexi-
mide-treated cells . Mouse melanoma ce ll s were seeded 'into 75_cm 2 flasks 
and either left un treated (control), o r treated with either cycloheximide 
(10- 5 M, 0 ). MSH (2 X 10- 7 M, 181). or to both MSI-I and cyclohexinude 
(_ ) for the times indicated. Ccl.ls were treated with cycloheximide 30 min 
before the addition of MSH. Ce ll s were re moved from Aasks at the times 
indicated, and tyrosinase I11R.NA levels were dctermined as described in 
Jlrlat"rials nlld Methods. T he normal ized tyrosinase I1IRNA va lue fo r control 
cultures was 337 vo lumetric uni ts. Values arc avera~es of tripli ca tes ± SO. 
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these gene-activating factors increase slowly in either abundance or 
activity over tinle and, thus, the transcriptional response slowly 
increases. Alternatively, although the transcriptional factors needed 
for the MSH/cAMP induction of the tyrosinase gene are present, 
the unstimulated cell may also contain some tyrosinase gene-
inhibitory factors, which are slowly inactivated by MSH. 
Although there are numerous examples in other cell types of a 
cAMP-mediated stabilization effect on specific mRNAs, MSH 
apparently does not act to increase the half-life of tyrosinase 
mRNA. We addressed the effect of MSH on the stability of 
ryrosinase mRNA by using the RNA synthesis inh.ibitor, DRB, 
which has been shown to selectively and reversibly inhibit the 
synthesis of heterogeneous nuclear RNA in mammalian ceLIs 
(Sehgal et ai, 1976) . Measuring preformed message decay after 
administration of DRB to block new mRNA synthesis is a conve-
nient way to measure the half-life of the message and to determine 
the effect of hormone on the stability of the message. The results 
from these studies indicated a tyrosinase mRNA half-life of approx-
imately 4 h, a value that correlates wen with the decay kinetics 
observed when MSH is removed from cultures. We have also 
determined the half-life of tyrosinase mRNA and the effect ofMSH 
on tyrosinase mRNA stabilization more directly (without inhibi-
tors) by utilizing DNA hybridization to m easure the decay of 
preformed eH]uridine-labeled tyrosinase mRNA in either control 
or MSH-treated cultures (Hod and Hanson, 1988). In this type of 
analysis, mRNA is first labeled with [3H]uridine and then cells are 
cultured either with or without hormone. At various times, RNA is 
prepared from cultures and hybridized to filters containing tyrosi-
nase eDNA. The amount of labeled tyrosinase mRNA hybridized 
to tbe filters is determined by scintillation cOl1.l1ting. Using this type 
of analysis, we again found that the message decayed with a half-life 
of about 4-5 h whether or not cells were treated with MSH. 
cAMP has been shown to mediate its transcription effects through 
a cAMP-response element in the 5' -flanking region of many genes, 
which has the consensus palindromic sequence, TGACGTCA 
(Montmini et ai, 1986; deGroot and Sassone-Corsi, 1993). It is 
tempting to speculate that the response mediated by MSH is also 
through a CRE present in the promoter of the tyrosinase gene. A 
sequ ence analysis of the 5' -flanking region of the tyrosinase gene, 
however, indicates that there are no consensus CREs present 
(Kluppel et ai, 1991; Tanaka et aI, 1992; Fuller et ai, 1993) . The 
presence of a CRE sequence is not obligatory for cAMP respon-
siveness as evidenced by reports of some genes that can be induced 
by cAMP but that do not contain a consensus CRE (Comb et al 
1986, Parker and Schimmel', 1993). In addition, an activator 
protein 2-binding site (AP-2) has also been shown to mediate 
cAMP responsiveness in some genes (Comb et aI, 1986; Imagawa et 
ai, 1987), and, in this regard, the mouse tyrosinase gene promoter 
region does contain a putative AP-2 site. 
We have not been able to demonstrate significant increase in 
CAT activity in ce LI s transfected with CAT reporter constructs 
bearing up to 3 .7 kb of tyrosinase gene promoter sequence and 
treated with either MSH, dibutyryl cAMP, or with isobutylmeth-
ylxanthine (Funer et ai, 1993). Similar negative results have been 
reported by Ganss and co-workers (Ganss et ai, 1994) . In their 
studies a 270-bp tyrosinase gene promoter/CAT reporter gene 
construct was stably introduced into B16 mouse melanoma cens . 
Cells were then treated with the adenylate cyclase activator, 
forskolin, and tyrosinase CAT mRNA levels were m easured at 
variou s times after treatment. Although tyrosinase mRNA levels 
were found to increase 4-fold in cells treated with forskolin for 4 d , 
no change in CAT mRNA levels was detected. 
We have recently begun to examin e the role of sequences within 
the first exon of the tyrosinase gene in mediating the cAMP 
induction of transcription. Sequence analysis of the first exon of the 
tyrosinase gene has identified an element that resembles the 
MSH R.EGULATION OF TYR.OSINASE mR.NA 693 
consensus CRE. We have now been able to demonstrate that a 
region of the first exon containing this elem ent does confer 
MSH/cAMP responsiveness to a reporter gene (Rungta D, Corn 
TD, Fuller BB, unpublished observations). Studies are underway to 
detern~ine w hether tllere are otl1er elements in the tyrosinase gene 
that are involved in transcriptional activation of the gene by MSH. 
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